Skinbiotherapeutics Share Discussion Threads

[michaelmouse] 20/11/2018 14:25

Interesting comparison with SKIN:-



"Balanced Microbiome Labskin Certified:
Confirmation of Labskin test results showing a balanced microbiome that contributes a positive outcome to skin treatment can now be certified for our clients' cosmetic and skin care products."

Except SKIN is actually making revenues and valued at just £1.5m, whereas SBTX is making no revenues and valued at £19m.

Not interested in either. I fully expect SBTX to be less than 1p in the fullness of time.

[manc10] 20/11/2018 14:19

mr trakm8 is back lol

[rathean] 20/11/2018 14:07

You just sound lonely ;)This is not pharma, it's a marketable brand with some skincare benefits with no adverse reactions unless you wear tube after tube of it... and assuming these final trials come in positive.Imo the share price could easily test 50p on successful completion of this trial given their pre-commercisation already in place.All IMHO ofc, dyor or just sit in your PJs whining at your laptop screen... up to you.

[michaelmouse] 20/11/2018 13:31

I think you'll find it's a pointless RNS which regurgitates everything you already know except the fact that the first human study demonstrated that their "quackery" does SFA.

The RNS is a desperate attempt to prop up the price of an massively overvalued company with zero revenues in a bear market.

Even a whiff that results are not as good as hoped and the share price will rapidly sink below a penny.

[riskybusiness1] 20/11/2018 10:16

RNS highlights the main development risks have been ticked off. Eg manufacture scale up, freeze dry stability and safety. All there is now is efficacy which has already been proven in laboratory and can be played with in terms of dosage. Positioned really nicely now.

[dire cons] 20/11/2018 06:01

'Topical probiotics and their lysates have been shown to be of value in treating acne. A topical product containing a 5% extract of Lactobacillus plantarum was found to reduce erythema, acne lesion size and improve skin barrier in patients with acne.'
Nice one.

[jammyjim] 19/11/2018 23:58

Is Rayrac the caped Crusader of the share world? Dedicating all of his time no matter if it’s day or night he will be there . Protecting people from making decisions for themselves. Even though he is not invested in the shares himself. I really can’t see why he bothers.

[rayrac] 19/11/2018 23:23

Hype? Seems that’s so.

[bayetya] 14/11/2018 22:06

Joyjoy, I meant more old rns's from other companies, not more from sbtx

[joyjoy13] 14/11/2018 17:38

Bayetya
Thanks for reply.
But I still only received one today, dated 7 November will old news, from RNS alerts website.
If there is a new one, could you post it here...
Much appreciated

[bayetya] 14/11/2018 16:30

joyjoy, from rnsalerts - yes, more than just the sbtx one...

[joyjoy13] 14/11/2018 13:09

Anybody else receive an RNS email today for SBTX but it’s dated 7 November?

[onedayrodders] 13/11/2018 14:44

Problem is the final and most important test is not due to start until "Later this month" .. that's only a week or 2 away but the fact that is has definitely not started means quite a few will just hop off for now and look for the next hot short term.

AIM has evolved into a betting shop mentality with very few "investors" left.

[matt123d] 13/11/2018 12:42

Obviously more than one way to profit but shorting when price reaches a prior high (double top) isn't a valid strategy, only know that was a level after it's actually dropped, if you shorted every time price reached a potential double top you'd soon be bust as it's actually more probable that price breaks out.

[danatkins] 13/11/2018 11:43

Then we disagree sir always two sides. As an observation there was a double top which could have been used for a small short and you could have added on the way down and tightened your stop On the initial trade. So I see two opportunities. All in hindsight but valid donetheless. Good luck

[matt123d] 13/11/2018 11:29

Possibly but price could have just consolidated, no indication of a fall to 15p, reducing long exposure with the criteria you mentioned would have been prudent but to initiate a short requires more evidence, participants losing money is the greatest incentive to sell, without losers present then price is likely to just consolidate.

[danatkins] 13/11/2018 11:13

Sorry mat but disagree on high risk at 28p. Bollinger bands where stretched on the monthly and weekly and in theory gave a sell signal. Buy low sell high. You are correct with your theory of panic sellers so I hope your short works out but the risk is higher at this point but with news flow not likely to happen soon you should be good. Just hope the risk reward is worth it

[matt123d] 13/11/2018 11:01

Was higher risk at 28p. Now there are several months of participants in losing positions here who are more inclined to panic sell as price falls. Waiting for news to suddenly turn a stock with losing participants is unlikely to end well as people sell on any bounce relieved to retrieve some of their initial investment. It takes time for a stock to repair hence actually lower risk taking a short when I did.

[slartybartfaster] 13/11/2018 10:49

I would have been more impressed if you open a short at 28p! If big news arrives you give back 50% of any gains. Risk reward payoff isn't worth boasting about fella.

[matt123d] 13/11/2018 10:13

At the 15/16p level but no sign of demand yet so keeping my short running 13/14p the next area.

[rayrac] 12/11/2018 12:03

I wouldn’t make you a wealthy man for any reason slarty, so forget it! :))